Ashland Inc. (ASH) stock
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3025% above fair value
$75.27−1.45 (-1.89%)
Close on Nov 12, 2026Market cap $3.45BP/E –Yield 2.18%
Ashland EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ashland's EPS for the twelve months ending Jun 30, 2019 was $1.64, up 127.8% year over year. For fiscal 2025 it was -$18.23, down 642.6% from the year before. The highest annual figure on record is $16.41 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$18.23 | -642.6% |
| FY2024 | Sep 30, 2024 | $3.36 | +1.5% |
| FY2023 | Sep 30, 2023 | $3.31 | -79.8% |
| FY2022 | Sep 30, 2022 | $16.41 | +357.1% |
| FY2021 | Sep 30, 2021 | $3.59 | – |
| FY2020 | Sep 30, 2020 | -$8.39 | -202.9% |
| FY2019 | Sep 30, 2019 | $8.15 | +355.3% |
| FY2018 | Sep 30, 2018 | $1.79 | +17800.0% |
| FY2017 | Sep 30, 2017 | $0.01 | – |
| FY2016 | Sep 30, 2016 | -$0.47 | -110.4% |
| FY2015 | Sep 30, 2015 | $4.54 | +51.3% |
| FY2014 | Sep 30, 2014 | $3.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $0.35 | -46.2% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $0.34 | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$0.26 | -316.7% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$16.21 | -778.2% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $0.65 | +27.5% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$3.50 | -472.3% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $0.12 | -92.8% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.39 | +227.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $0.51 | -21.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $0.94 | -93.1% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $1.67 | +101.2% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $0.73 | -43.4% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $0.65 | -3.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $13.69 | +1388.0% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $0.83 | +36.1% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.29 | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $0.67 | +26.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $0.92 | -12.4% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $0.61 | -48.7% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$9.61 | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $0.53 | +231.3% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $1.05 | +87.5% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $1.19 | +3.5% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$0.76 | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $0.16 | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $0.56 | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.15 | -21.8% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$0.07 | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$0.92 | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$0.54 | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $1.47 | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$0.01 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?